- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02328092
A Double-blind Randomized Clinical Trial on the Efficacy of Magnetic Sacral Roots Stimulation for the Treatment of NE
September 12, 2020 updated by: Eman M. Khedr, Assiut University
Therapeutic Effect of Sacral Root Stimulation on Nocturnal Enuresis
The purpose of this study is to assess the efficacy of daily sacral root magnetic stimulation for 10 sessions in patients with nocturnal enuresis.Eligible patients were randomized to receive either real or sham repetitive sacral root magnetic stimulation (rSMS; 15 Hz with a total of 1500 pulses/session) for 10 sessions.
Evaluation was performed before starting treatment, immediately after the 5th and 10th treatment session, and 1 month later, using frequency of enuresis/week, visual analogue scale (VAS) and Quality of life.
Cortical excitability of upper and lower limbs were done before and after the end of sessions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to assess the efficacy of daily sacral root magnetic stimulation for 10 sessions in patients with nocturnal enuresis.
Eligible patients were randomized to receive either real or sham repetitive sacral root magnetic stimulation (rSMS; 15 Hz with a total of 1500 pulses/session) for 10 sessions.
Evaluation was performed before starting treatment, immediately after the 5th and 10th treatment session, and 1 month later, using frequency of enuresis/week, visual analogue scale (VAS) and Quality of life.
Cortical excitability of upper and lower limbs were done before and after the end of sessions.
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 20 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All subjects diagnosed as patients with primary monosymptomatic nocturnal enuresis according to the Diagnostic and statistical manual of mental disorders, 4th revised edn (DSM-IV)
Exclusion Criteria:
- We exclude any patient with pacemakers or any metallic devices
- Patients with evidence of urinary tract infection.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Real group
The real group received biphasic rSMS using a Magstim Super Rapid (Magstim, Whitland, UK) stimulator connected to a 120-mm outer diameter figure-of-8 air film cooling coil positioned in the midline over the sacral vertebrae (approximately 5 cm above the natal cleft, which approximates to the level of S2).
Stimulation was delivered at 15 Hz at 50% of maximum stimulator output (10 seconds on and 30 seconds off) with a total of 1500 pulses and the hand of the coil upward.
The stimulation was repeated for 10 sessions, 5 sessions per week and 2 days off.
|
Real rSMS (15 Hz at 50% of maximum stimulator output (10 seconds on and 30 seconds off) with a total of 1500 pulses and the hand of the coil upword.
The stimulation was repeated for 10 sessions, 5 sessions per week and 2 days off.
Sham rSMS received stimulation using the same coil, the same session frequency, in the same setting, but the coil was tilted 90.
|
Sham Comparator: Sham Group
The control group received sham rSMS stimulation using the same coil, the same session frequency, in the same setting, but the coil was tilted 90.
|
Real rSMS (15 Hz at 50% of maximum stimulator output (10 seconds on and 30 seconds off) with a total of 1500 pulses and the hand of the coil upword.
The stimulation was repeated for 10 sessions, 5 sessions per week and 2 days off.
Sham rSMS received stimulation using the same coil, the same session frequency, in the same setting, but the coil was tilted 90.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the number of bedwetting/week
Time Frame: 2.5 months
|
Measurment of number of bedwetting/week one month before session, session, after first and second week of stimulation and one month later
|
2.5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life assessment
Time Frame: 1.5 month
|
Assessment of Quality of life
|
1.5 month
|
VAS
Time Frame: 1.5 month
|
Measurment of VAS
|
1.5 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
December 18, 2014
First Submitted That Met QC Criteria
December 26, 2014
First Posted (Estimate)
December 31, 2014
Study Record Updates
Last Update Posted (Actual)
September 16, 2020
Last Update Submitted That Met QC Criteria
September 12, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- rSMS in nocturnal enuresis
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nocturnal Enuresis
-
University GhentCompletedMonosymptomatic Nocturnal EnuresisBelgium
-
University Hospital, GhentFerring PharmaceuticalsCompletedMonosymptomatic Nocturnal EnuresisBelgium
-
Lancashire Teaching Hospitals NHS Foundation TrustUniversity of Central LancashireCompletedEnuresis | Enuresis, NocturnalUnited Kingdom
-
Children's Hospital of Fudan UniversityCompleted
-
Cairo UniversityUnknownPrimary Monosymptomatic Nocturnal EnuresisEgypt
-
Ferring PharmaceuticalsCompleted
-
Gina LockwoodPottyMDRecruiting
-
Ferring PharmaceuticalsCompleted
-
Seoul National University HospitalCompletedEnuresis, Nocturnal, 2 (Disorder)
-
Fayoum University HospitalActive, not recruitingEnuresis | Nocturnal Enuresis | Enuresis, NocturnalEgypt
Clinical Trials on rSMS in treatment of Nocturnal Enuresis
-
Rabin Medical CenterUnknown
-
Walter Reed National Military Medical CenterCompletedType 2 DiabetesUnited States
-
Azienda Ospedaliera San Giovanni BattistaCompleted
-
University of Health Sciences LahoreRecruitingTreatment of Refractory GlaucomaPakistan
-
North-Western State Medical University named after...CompletedEdentulous | Teeth Replacement | Bounded Edentulous Space
-
University Hospital, ToulouseTerminatedAcute Ischemic StrokeFrance
-
PfizerCompletedNeurogenic Detrusor OveractivityBelgium
-
Assistance Publique - Hôpitaux de ParisVaincre la MucoviscidoseCompletedBack Pain | Chest Pain | Neck Pain | Cystic FibrosisFrance
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Assiut UniversityNot yet recruitingAnoplasty in Treatment of Post Hemorroidectomy Anal StenosisEgypt